Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome.

Barocas, Daniel A; Kawamoto, Hideki; Dreizin, David F; Howard, Marion E; Choi, Judy; Pitts, W Reid; You, Xueke; Tickoo, Satish K; Boorjian, Stephen A; Scherr, Douglas S

Barocas, Daniel A; Kawamoto, Hideki; Dreizin, David F; Howard, Marion E; Choi, Judy; Pitts, W Reid; You, Xueke; Tickoo, Satish K; Boorjian, Stephen A; Scherr, Douglas S.

Affiliation

Barocas DA; Department of Urology, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York 10021, USA.

Urology ; 66(5): 1134-9, 2005 Nov.

Article in En | MEDLINE | ID: mdl-16286153

Subject(s)

Carcinoma, Transitional Cell/enzymology; Cholestenone 5 alpha-Reductase/biosynthesis; Urologic Diseases/enzymology; Urologic Neoplasms/enzymology; Urothelium/enzymology; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell/diagnosis; Disease Progression; Female; Humans; Male; Middle Aged; Urologic Diseases/diagnosis; Urologic Neoplasms/diagnosis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urologic Diseases / Carcinoma, Transitional Cell / Urologic Neoplasms / Urothelium / Cholestenone 5 alpha-Reductase Type of study: Diagnostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Urology Year: 2005 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links